Rigel Pharmaceuticals (RIGL) Operating Leases: 2019-2025
Historic Operating Leases for Rigel Pharmaceuticals (RIGL) over the last 5 years, with Sep 2025 value amounting to $556,000.
- Rigel Pharmaceuticals' Operating Leases was N/A to $556,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $556,000, marking a year-over-year change of. This contributed to the annual value of $285,000 for FY2023, which is 70.68% down from last year.
- As of Q3 2025, Rigel Pharmaceuticals' Operating Leases stood at $556,000, which was down 22.13% from $714,000 recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Operating Leases registered a high of $17.2 million during Q1 2021, and its lowest value of $100,000 during Q1 2024.
- Moreover, its 3-year median value for Operating Leases was $592,000 (2023), whereas its average is $551,875.
- In the last 5 years, Rigel Pharmaceuticals' Operating Leases slumped by 96.07% in 2021 and then skyrocketed by 764.00% in 2025.
- Rigel Pharmaceuticals' Operating Leases (Quarterly) stood at $759,000 in 2021, then grew by 28.06% to $972,000 in 2022, then slumped by 70.68% to $285,000 in 2023, then tumbled by 87.53% to $100,000 in 2024, then skyrocketed by 764.00% to $556,000 in 2025.
- Its Operating Leases was $556,000 in Q3 2025, compared to $714,000 in Q2 2025 and $864,000 in Q1 2025.